Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy, in Patients With Metastatic Renal Cell Carcinoma in Daily Clinical Practice

NCT02282579 is registered in ClinicalTrials.gov with Spanish Oncology Genito-Urinary Group as lead sponsor.

NCT NCT02282579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02282579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy, in Patients With Metastatic Renal Cell Carcinoma in Daily Clinical Practice
Lead sponsor
Spanish Oncology Genito-Urinary Group
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
April 30, 2015
Enrollment
300 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell carcinoma